vTv Therapeutics Inc. (VTVT) News
Track canonical SquawkNews coverage tagged to VTVT, vTv Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 15, 2026, 08:05 PM UTC
L
VTVT management to participate in September investor conferences
VTVT announced management will participate in September investor conferences. The company is advancing cadisegliatin, a novel oral investigational therapy for type 1 diabetes (T1D).
EQUITY | Sep 02, 2026, 12:07 PM UTC
L
VTVT - vTv Therapeutics to Participate in September Investor Conferences
VTVT - vTv Therapeutics to Participate in September Investor Conferences
EQUITY | Sep 02, 2026, 12:01 PM UTC
L
vTv Therapeutics announces Nasdaq Rule 5635(c)(4) inducement grants
vTv Therapeutics (VTVT) announces inducement grants under Nasdaq Listing Rule 5635(c)(4), with details provided by the company in its release; no grant size or terms were included in the feed.
REGULATION | Aug 19, 2026, 08:06 PM UTC
L
VTVT - vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
VTVT - vTv Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 06, 2026, 12:00 PM UTC
L
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
VTVT - vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
EQUITY | Jul 28, 2026, 08:06 PM UTC